FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109063792> ?p ?o ?g. }

• W2109063792 endingPage "1432" @default.
• W2109063792 startingPage "1423" @default.
• W2109063792 abstract "Statins are inhibitors of the rate-limiting enzyme in cholesterol synthesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. In addition to reducing LDL cholesterol, statin treatment increases the levels of the antiatherogenic HDL and its major apolipoprotein apoA-I. Here, we investigated the molecular mechanisms of apoA-I regulation by statins. Treatment with statins increased apoA-I mRNA levels in human HepG2 hepatoma cells, and this effect was reversed by the addition of mevalonate, implicating HMG-CoA reductase as the relevant target of these drugs. Pretreatment with Actinomycin D abolished the increase of apoA-I mRNA, indicating that statins act at the transcriptional level. Indeed, statins increased the human apoA-I promoter activity in transfected cells, and we have identified a statin response element that coincides with a PPARalpha response element known to confer fibrate responsiveness to this gene. The statin effect could be abolished not only by mevalonate, but also by geranylgeranyl pyrophosphate, whereas inhibition of geranylgeranyl transferase activity or treatment with an inhibitor of the Rho GTP-binding protein family increased PPARalpha activity. Using dominant negative forms of these proteins, we found that Rho A itself mediates this response. Because cotreatment with statins and fibrates activated PPARalpha in a synergistic manner, these observations provide a molecular basis for combination treatment with statins and fibrates in coronary heart disease." @default.
• W2109063792 created "2016-06-24" @default.
• W2109063792 creator A5001127450 @default.
• W2109063792 creator A5007407879 @default.
• W2109063792 creator A5011123960 @default.
• W2109063792 creator A5020324120 @default.
• W2109063792 creator A5035855869 @default.
• W2109063792 creator A5037746077 @default.
• W2109063792 creator A5054418976 @default.
• W2109063792 creator A5062570446 @default.
• W2109063792 creator A5085801245 @default.
• W2109063792 date "2001-06-01" @default.
• W2109063792 modified "2023-10-14" @default.
• W2109063792 title "Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I" @default.
• W2109063792 cites W143025234 @default.
• W2109063792 cites W1505047300 @default.
• W2109063792 cites W1549577793 @default.
• W2109063792 cites W1567127662 @default.
• W2109063792 cites W1608005125 @default.
• W2109063792 cites W1919928987 @default.
• W2109063792 cites W1965418020 @default.
• W2109063792 cites W1981101682 @default.
• W2109063792 cites W1983498453 @default.
• W2109063792 cites W1985683101 @default.
• W2109063792 cites W1990321264 @default.
• W2109063792 cites W1991055758 @default.
• W2109063792 cites W1992864925 @default.
• W2109063792 cites W1993524316 @default.
• W2109063792 cites W1994967652 @default.
• W2109063792 cites W2000790999 @default.
• W2109063792 cites W2005674716 @default.
• W2109063792 cites W2011591511 @default.
• W2109063792 cites W2020690650 @default.
• W2109063792 cites W2028947098 @default.
• W2109063792 cites W2029186389 @default.
• W2109063792 cites W2035210330 @default.
• W2109063792 cites W2037085464 @default.
• W2109063792 cites W2038381362 @default.
• W2109063792 cites W2039999119 @default.
• W2109063792 cites W2042584344 @default.
• W2109063792 cites W2046268728 @default.
• W2109063792 cites W2047599067 @default.
• W2109063792 cites W2049647259 @default.
• W2109063792 cites W2050717908 @default.
• W2109063792 cites W2054851194 @default.
• W2109063792 cites W2055073916 @default.
• W2109063792 cites W2055181868 @default.
• W2109063792 cites W2055323243 @default.
• W2109063792 cites W2056768855 @default.
• W2109063792 cites W2057654931 @default.
• W2109063792 cites W2060105709 @default.
• W2109063792 cites W2060351304 @default.
• W2109063792 cites W2066092624 @default.
• W2109063792 cites W2067236087 @default.
• W2109063792 cites W2071124826 @default.
• W2109063792 cites W2072308694 @default.
• W2109063792 cites W2078406560 @default.
• W2109063792 cites W2078974893 @default.
• W2109063792 cites W2090891207 @default.
• W2109063792 cites W2094768566 @default.
• W2109063792 cites W2096791952 @default.
• W2109063792 cites W2097176237 @default.
• W2109063792 cites W2103995568 @default.
• W2109063792 cites W2107735993 @default.
• W2109063792 cites W2114437978 @default.
• W2109063792 cites W2123652234 @default.
• W2109063792 cites W2129747400 @default.
• W2109063792 cites W2129788418 @default.
• W2109063792 cites W2132432570 @default.
• W2109063792 cites W2138533227 @default.
• W2109063792 cites W2139002144 @default.
• W2109063792 cites W2142239045 @default.
• W2109063792 cites W2145448066 @default.
• W2109063792 cites W2146905815 @default.
• W2109063792 cites W2153435788 @default.
• W2109063792 cites W2159633079 @default.
• W2109063792 cites W2165737207 @default.
• W2109063792 cites W2169667471 @default.
• W2109063792 cites W2171533490 @default.
• W2109063792 cites W2185944592 @default.
• W2109063792 cites W2329543325 @default.
• W2109063792 cites W2397257983 @default.
• W2109063792 cites W2887225365 @default.
• W2109063792 cites W4254311600 @default.
• W2109063792 cites W4385778326 @default.
• W2109063792 doi "https://doi.org/10.1172/jci10852" @default.
• W2109063792 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/209316" @default.
• W2109063792 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11390424" @default.
• W2109063792 hasPublicationYear "2001" @default.
• W2109063792 type Work @default.
• W2109063792 sameAs 2109063792 @default.
• W2109063792 citedByCount "403" @default.
• W2109063792 countsByYear W21090637922012 @default.
• W2109063792 countsByYear W21090637922013 @default.
• W2109063792 countsByYear W21090637922014 @default.
• W2109063792 countsByYear W21090637922015 @default.
• W2109063792 countsByYear W21090637922016 @default.
• W2109063792 countsByYear W21090637922017 @default.

• next